Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 616 AL 630

Current Insights of Nanocarrier-Mediated Gene Therapeutics to Treat Potential Impairment of Amyloid Beta Protein and Tau Protein in Alzheimer's Disease

Jain U, Johari S, Srivastava P.

Mol Neurobiol. 2024 Apr;61(4):1969-1989. doi: 10.1007/s12035-023-03671-7. Epub 2023 Oct 13.

Memantine: Updating a rare success story in pro-cognitive therapeutics

Karimi Tari P, Parsons CG, Collingridge GL, Rammes G.

Neuropharmacology. 2024 Feb 15;244:109737. doi: 10.1016/j.neuropharm.2023.109737. Epub 2023 Oct 11.

The effects of different acetylcholinesterase inhibitors on EEG patterns in patients with Alzheimer's disease: A systematic review

Arjmandi-Rad S, Vestergaard Nieland JD, Goozee KG, Vaseghi S.

Neurol Sci. 2024 Feb;45(2):417-430. doi: 10.1007/s10072-023-07114-y. Epub 2023 Oct 16.

Oligodendrocytes Play a Critical Role in White Matter Damage of Vascular Dementia

Zhang H, Yang Y, Zhang J, Huang L, Niu Y, Chen H, Liu Q, Wang R.

Neuroscience. 2024 Feb 6;538:1-10. doi: 10.1016/j.neuroscience.2023.10.018. Epub 2023 Oct 31.

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease

Cummings J, Osse AML, Cammann D, Powell J, Chen J.

BioDrugs. 2024 Jan;38(1):5-22. doi: 10.1007/s40259-023-00633-2. Epub 2023 Nov 13.

Efficacy of anti-amyloid-ß monoclonal antibody therapy in early Alzheimer's disease: a systematic review and meta-analysis

Dantas JM, Mutarelli A, Navalha DDP, Dagostin CS, Romeiro PHCL, Felix N, Nogueira A, Batista S, Teixeira L, Caramelli P.

Neurol Sci. 2024 Jun;45(6):2461-2469. doi: 10.1007/s10072-023-07194-w. Epub 2023 Nov 17.

Clarity on the blazing trail: clearing the way for amyloid-removing therapies for Alzheimer's disease

Lian Y, Jia YJ, Wong J, Zhou XF, Song W, Guo J, Masters CL, Wang YJ.

Mol Psychiatry. 2024 Feb;29(2):297-305. doi: 10.1038/s41380-023-02324-4. Epub 2023 Nov 24.

Environmental Toxins and Alzheimer's Disease: a Comprehensive Analysis of Pathogenic Mechanisms and Therapeutic Modulation

Dhapola R, Sharma P, Kumari S, Bhatti JS, HariKrishnaReddy D.

Mol Neurobiol. 2024 Jun;61(6):3657-3677. doi: 10.1007/s12035-023-03805-x. Epub 2023 Nov 25.

Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment

Chaves JCS, Dando SJ, White AR, Oikari LE.

Biochim Biophys Acta Mol Basis Dis. 2024 Feb;1870(2):166967. doi: 10.1016/j.bbadis.2023.166967. Epub 2023 Nov 24.

Targeting synapse function and loss for treatment of neurodegenerative diseases

Dejanovic B, Sheng M, Hanson JE.

Nat Rev Drug Discov. 2024 Jan;23(1):23-42. doi: 10.1038/s41573-023-00823-1. Epub 2023 Nov 27.

Pathogenesis of Depression in Alzheimer's Disease

Zhan Q, Kong F, Shao S, Zhang B, Huang S.

Neurochem Res. 2024 Mar;49(3):548-556. doi: 10.1007/s11064-023-04061-0. Epub 2023 Nov 28.

Targets, trials and tribulations in Alzheimer therapeutics

Gharat R, Dixit G, Khambete M, Prabhu A.

Eur J Pharmacol. 2024 Jan 5;962:176230. doi: 10.1016/j.ejphar.2023.176230. Epub 2023 Dec 1.

Therapeutic potential of natural products against Alzheimer's disease via autophagic removal of Aβ

Hu M, Ying X, Zheng M, Wang C, Li Q, Gu L, Zhang X.

Brain Res Bull. 2024 Jan;206:110835. doi: 10.1016/j.brainresbull.2023.110835. Epub 2023 Dec 1.

Regulation of tau by peptidyl-prolyl isomerases

Zhuang S, Chakraborty P, Zweckstetter M.

Curr Opin Struct Biol. 2024 Feb;84:102739. doi: 10.1016/j.sbi.2023.102739. Epub 2023 Dec 7.

Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer's Disease

Sequeira RC, Godad A.

Mol Neurobiol. 2024 Jul;61(7):4203-4221. doi: 10.1007/s12035-023-03839-1. Epub 2023 Dec 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias